Angiotensin-(1 7) stimulates the phosphorylation of JAK2, IRS-1 and Akt in rat heart in vivo: role of the AT1 and Mas receptors. (Q53553738)

15 May 2018

title

Angiotensin-(1 7) stimulates the phosphorylation of JAK2, IRS-1 and Akt in rat heart in vivo: role of the AT1 and Mas receptors. (English)

1 reference

15 May 2018

0 references

Jorge F Giani

1

1 reference

15 May 2018

Mariela M Gironacci

2

1 reference

15 May 2018

Marina C Muñoz

3

1 reference

15 May 2018

Clara Peña

4

1 reference

15 May 2018

Daniel Turyn

5

1 reference

15 May 2018

Fernando P Dominici

6

1 reference

15 May 2018

publication date

11 May 2007

1 reference

15 May 2018

American Journal of Physiology Heart and Circulatory Physiology

published in

1 reference

15 May 2018

volume

293

1 reference

15 May 2018

issue

2

1 reference

15 May 2018

page(s)

H1154-63

1 reference

15 May 2018

Insulin signaling in heart muscle: lessons from genetically engineered mouse models.

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01395.2006

Effects of long-term caloric restriction on early steps of the insulin-signaling system in mouse skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01395.2006

Suppressor of cytokine signaling-3 Provides a novel interface in the cross-talk between angiotensin II and insulin signaling systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01395.2006

The cross-talk between angiotensin and insulin differentially affects phosphatidylinositol 3-kinase- and mitogen-activated protein kinase-mediated signaling in rat heart: implications for insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01395.2006

Angiotensin II subtype 2 receptor activation inhibits insulin-induced phosphoinositide 3-kinase and Akt and induces apoptosis in PC12W cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01395.2006

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01395.2006

Influence of the crosstalk between growth hormone and insulin signalling on the modulation of insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01395.2006

Counterregulatory actions of angiotensin-(1-7).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01395.2006

Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1-7) in regulation of cardiovascular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01395.2006

Angiotensin-converting enzyme 2 and angiotensin-(1-7): an evolving story in cardiovascular regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01395.2006

Angiotensin-(1-7): cardioprotective effect in myocardial ischemia/reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01395.2006

Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels. A potential role for serine phosphorylation in insulin/angiotensin II crosstalk

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01395.2006

Crosstalk between insulin and angiotensin II signalling systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01395.2006

An angiotensin II AT1 receptor antagonist, telmisartan augments glucose uptake and GLUT4 protein expression in 3T3-L1 adipocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01395.2006

Blockade of the renin-angiotensin system decreases adipocyte size with improvement in insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01395.2006

Angiotensin-(1-7) inhibitory mechanism of norepinephrine release in hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01395.2006

Selective angiotensin II receptor antagonism reduces insulin resistance in obese Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01395.2006

Why blockade of the renin-angiotensin system reduces the incidence of new-onset diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01395.2006

Interleukins 2, 4, 7, and 15 stimulate tyrosine phosphorylation of insulin receptor substrates 1 and 2 in T cells. Potential role of JAK kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01395.2006

G-protein-coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01395.2006

Effects of angiotensin-converting enzyme inhibitors on glucose uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01395.2006

Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01395.2006

Convergent signal transduction pathways controlling cardiomyocyte survival and function: the role of PI 3-kinase and Akt.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01395.2006

Irbesartan restores the in-vivo insulin signaling pathway leading to Akt activation in obese Zucker rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01395.2006

Angiotensin II-induced insulin resistance is associated with enhanced insulin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01395.2006

Angiotensin II induces insulin resistance independent of changes in interstitial insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01395.2006

Angiotensin II induces tyrosine phosphorylation of insulin receptor substrate 1 and its association with phosphatidylinositol 3-kinase in rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01395.2006

Angiotensin-(1-7) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01395.2006

Angiotensin-(1-7) and its receptor as a potential targets for new cardiovascular drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01395.2006

Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01395.2006

Release of vasopressin from the rat hypothalamo-neurohypophysial system by angiotensin-(1-7) heptapeptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01395.2006

Akt signaling mediates postnatal heart growth in response to insulin and nutritional status

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01395.2006

Angiotensin II type-1 receptor blocker valsartan enhances insulin sensitivity in skeletal muscles of diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01395.2006

Critical nodes in signalling pathways: insights into insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01395.2006

The multi-faceted cross-talk between the insulin and angiotensin II signaling systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01395.2006

Cross-talk between the insulin and angiotensin signaling systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01395.2006

Angiotensin-(1-7) acts as a vasodepressor agent via angiotensin II type 2 receptors in conscious rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01395.2006

Alterations in the early steps of the insulin-signaling system in skeletal muscle of GH-transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01395.2006

Effect of captopril, losartan, and bradykinin on early steps of insulin action

21 January 2018

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.2337/DIAB.46.12.1950

Identifiers

DOI

10.1152/AJPHEART.01395.2006

1 reference

15 May 2018

PubMed ID

17496209

1 reference

15 May 2018